Expired European patentEurope
NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
EP 1014968 B1 · Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 13, 1997 and granted February 18, 2004. A European patent lasts at most 20 years from filing, so its term ended October 13, 2017.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by April 13, 2023.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledOctober 13, 1997
PublishedJuly 5, 2000
GrantedFebruary 18, 2004
Term endedOctober 13, 2017
Application numberEP 97944200
Classification (CPC)A61P43/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.